20th Anniversary of Pharmaceuticals—Advances in Pathophysiology, Pharmacology and Neuroprotection in Glaucoma
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 15 July 2024 | Viewed by 948
Special Issue Editor
Special Issue Information
Dear Colleagues,
It is our great delight and honor to celebrate the 20th Anniversary of Pharmaceuticals with a Special Issue on glaucoma, and to invite researchers to contribute a manuscript of original research, review, or short communication. The articles from this Special Issue will be compiled into a dedicated book.
As you are aware, the many forms of glaucoma afflict millions of people worldwide. There is still a critical need to better understand the genetics, pathophysiology, and clinical ramifications connected with this heterogeneous optic neuropathy. As leaders in the glaucoma field, I cordially invite you to contribute an original or a review article covering the pathogenesis and/or pharmacology of current treatment modalities for ocular hypertension and glaucoma in an area of your expertise. This can also include neuroprotection for glaucomatous optic neuropathy, animal models, and related topics such as diagnosis, devices, AI, and, of course, the pharmacology of the receptors/enzymes/ion-channels implicated in the disease process or treatment(s).
Dr. Najam A. Sharif
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Genetics & Epigenetics
- Enzymes
- Ion-channels
- miRNAs
- Gene and Cell Therapies
- Optogenetics
- Novel techniques/technologies
- Receptors
- Ocular hypertension
- Intraocular pressure
- Retina
- Optic Nerve
- Brain Visual centers
- Animal Models of Glaucoma
- Neuroprotection
